Deyev SM - Search Results

1

Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis.

Semenova G, Stepanova DS, Dubyk C, Handorf E, Deyev SM, Lazar AJ, Chernoff J. Semenova G, et al. Among authors: deyev sm. Oncogene. 2017 Sep 21;36(38):5421-5431. doi: 10.1038/onc.2017.143. Epub 2017 May 22. Oncogene. 2017. PMID: 28534510 Free PMC article.

2

Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.

Semenova G, Stepanova DS, Deyev SM, Chernoff J. Semenova G, et al. Among authors: deyev sm. Biochimie. 2017 Apr;135:1-5. doi: 10.1016/j.biochi.2017.01.001. Epub 2017 Jan 6. Biochimie. 2017. PMID: 28065690 Free PMC article.

3

ERBB oncogene proteins as targets for monoclonal antibodies.

Polanovski OL, Lebedenko EN, Deyev SM. Polanovski OL, et al. Among authors: deyev sm. Biochemistry (Mosc). 2012 Mar;77(3):227-45. doi: 10.1134/S0006297912030029. Biochemistry (Mosc). 2012. PMID: 22803941 Review.

4

A novel far-red fluorescent xenograft model of ovarian carcinoma for preclinical evaluation of HER2-targeted immunotoxins.

Zdobnova T, Sokolova E, Stremovskiy O, Karpenko D, Telford W, Turchin I, Balalaeva I, Deyev S. Zdobnova T, et al. Oncotarget. 2015 Oct 13;6(31):30919-28. doi: 10.18632/oncotarget.5130. Oncotarget. 2015. PMID: 26436696 Free PMC article.

5

Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.

Deyev S, Vorobyeva A, Schulga A, Proshkina G, Güler R, Löfblom J, Mitran B, Garousi J, Altai M, Buijs J, Chernov V, Orlova A, Tolmachev V. Deyev S, et al. Mol Pharm. 2019 Mar 4;16(3):995-1008. doi: 10.1021/acs.molpharmaceut.8b00922. Epub 2019 Feb 8. Mol Pharm. 2019. PMID: 30608701

6

Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment.

Shipunova VO, Komedchikova EN, Kotelnikova PA, Zelepukin IV, Schulga AA, Proshkina GM, Shramova EI, Kutscher HL, Telegin GB, Kabashin AV, Prasad PN, Deyev SM. Shipunova VO, et al. Among authors: deyev sm. ACS Nano. 2020 Oct 27;14(10):12781-12795. doi: 10.1021/acsnano.0c03421. Epub 2020 Sep 16. ACS Nano. 2020. PMID: 32935975

7

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.

Xu T, Schulga A, Konovalova E, Rinne SS, Zhang H, Vorontsova O, Orlova A, Deyev SM, Tolmachev V, Vorobyeva A. Xu T, et al. Among authors: deyev sm. Int J Mol Sci. 2023 Feb 2;24(3):2838. doi: 10.3390/ijms24032838. Int J Mol Sci. 2023. PMID: 36769161 Free PMC article.

8

Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.

Edelweiss E, Balandin TG, Ivanova JL, Lutsenko GV, Leonova OG, Popenko VI, Sapozhnikov AM, Deyev SM. Edelweiss E, et al. Among authors: deyev sm. PLoS One. 2008 Jun 18;3(6):e2434. doi: 10.1371/journal.pone.0002434. PLoS One. 2008. PMID: 18560598 Free PMC article.

9

Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.

Deyev SM, Lebedenko EN. Deyev SM, et al. Bioessays. 2008 Sep;30(9):904-18. doi: 10.1002/bies.20805. Bioessays. 2008. PMID: 18693269

10

Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.

Balandin TG, Edelweiss E, Andronova NV, Treshalina EM, Sapozhnikov AM, Deyev SM. Balandin TG, et al. Among authors: deyev sm. Invest New Drugs. 2011 Feb;29(1):22-32. doi: 10.1007/s10637-009-9329-2. Epub 2009 Sep 30. Invest New Drugs. 2011. PMID: 19789841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters